PRIA Logo™
115-hr-5926115th Congress

Naloxone Guidelines Act of 2018

Sponsored By: Representative Keating, William R. [D-MA-9]

Unknown

Summary

Naloxone Guidelines Act of 2018 This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone). The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including: co-prescription with an opioid; safe dosages; prescription for non-patients; and standing orders (i.e., orders that allow dispensing without a prescription).

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Keating, William R. [D-MA-9]

MA • D

Cosponsors

  • Rep. Rothfus, Keith J. [R-PA-12]

    PA • R

    Sponsored 5/23/2018

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation